← Eichor
Study identifier: NCT06740318 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Recompensation in Alcohol Related Hepatitis

Condition: Alcoholic Hepatitis (AH)  ·  Sponsor: Nina Kimer

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Genetic activity and metabolic changes may be part of the pathogenesis in alcohol related hepatitis. We do not know exactly how alcohol cessation affects liver functions and metabolism. The aim of this study is to assess the impact of alcohol cessation in patients with alcohol related hepatitis and gain knowledge of the metabolic and genetic functions of the liver during remission and recompensation from alcohol related hepatitis. The study will assess 1. The effect of alcohol cessation on the liver. 2. The biological mechanisms involved in healing after alvohol-cessation 3. The effect of motivational enhcament therapy in alcohol cessation after alcohol related hepatitis. 4. The metabolic changes of lipids and proteins in the liver Participants are offered motivational enhancement therapy and standard of care.

This description comes directly from the study's public registry record.

Talk to the study team

Nina Kimer, MD, PhD  ·  +4525140961  ·  nina.kimer@regionh.dk

Niels P Klausen, MD  ·  +4538621968  ·  niels.peter.riedel.klausen@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital HvidovreHvidovre, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06740318